A new ADHD drug targets three brain chemicals instead of two. Here's what that means
A new medicine for attention-deficit/hyperactivity disorder (ADHD) has just entered the treatment toolbox: centanafadine, a once-daily tablet sold under the brand name Simtriyo.
We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.